These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7794712)

  • 1. Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease.
    Taylor A; Sherman NH; Norman ME
    Pediatr Nephrol; 1995 Apr; 9(2):173-5. PubMed ID: 7794712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia.
    Seikaly MG; Baum M
    Pediatrics; 2001 Jul; 108(1):E6. PubMed ID: 11433085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren.
    Patzer L; van't Hoff W; Shah V; Hallson P; Kasidas GP; Samuell C; de Bruyn R; Barratt TM; Dillon MJ
    J Pediatr; 1999 Nov; 135(5):611-7. PubMed ID: 10547250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study.
    Jin C; Zhang C; Ni X; Zhao Z; Xu L; Wu B; Chi Y; Jiajue R; Jiang Y; Wang O; Li M; Xing X; Meng X; Xia W
    Osteoporos Int; 2022 Jun; 33(6):1385-1395. PubMed ID: 35088103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia.
    Eddy MC; McAlister WH; Whyte MP
    Bone; 1997 Dec; 21(6):515-20. PubMed ID: 9430241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrocalcinosis and its relationship to treatment of hereditary rickets.
    Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR
    J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
    Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA
    Nephron; 1993; 64(4):526-31. PubMed ID: 8396209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rickets, the continuing challenge.
    Glorieux FH
    N Engl J Med; 1991 Dec; 325(26):1875-7. PubMed ID: 1660099
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.
    Alon US; Monzavi R; Lilien M; Rasoulpour M; Geffner ME; Yadin O
    Pediatr Nephrol; 2003 Feb; 18(2):155-8. PubMed ID: 12579406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.
    Blydt-Hansen TD; Tenenhouse HS; Goodyer P
    Pediatr Nephrol; 1999 Sep; 13(7):607-11. PubMed ID: 10460513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical and surgical therapy of familial hypophosphatemic vitamin D resistant rickets with ambulation disorders].
    Berio A; Pinelli G
    Minerva Pediatr; 1997 Oct; 49(10):487-93. PubMed ID: 9557495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse.
    Alon U; Donaldson DL; Hellerstein S; Warady BA; Harris DJ
    J Pediatr; 1992 Jun; 120(6):899-905. PubMed ID: 1317418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of typical nephrocalcinosis ultrasound findings in premature infants during enteral calcium and phosphate administration].
    Pfitzer A; Nelle M; Rohrschneider W; Linderkamp O; Tröger J
    Z Geburtshilfe Neonatol; 1998; 202(4):159-63. PubMed ID: 9783374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrocalcinosis in X-linked hypophosphataemic rickets: just how serious is the problem?
    Cole DE
    Clin Invest Med; 1994 Apr; 17(2):131-2. PubMed ID: 8004849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.